Results 41 to 50 of about 14,081 (169)
Head &Neck, EarlyView.ABSTRACT Background Nasopharyngeal carcinoma (NPC) is uncommon in many populations. Most existing clinical evidence comes from endemic areas, where Epstein–Barr virus (EBV)‐associated subtypes predominate. We analyzed patterns of failure in a population‐based cohort from Denmark, a low‐incidence setting.
Anne Marie Lindegaard +14 more
wiley +1 more source
Frontiers in Oncology, 2021 IntroductionStereotactic radiotherapy may improve the prognosis of oligometastatic patients. In the literature, there is very little data available that is specific to breast cancer.Materials and MethodsWe conducted a multicenter retrospective study. The
Pauline Lemoine +12 more
doaj +1 more source
Journal of Surgical Oncology, EarlyView.ABSTRACT Liver transplantation (LT) is the definitive treatment for early hepatocellular carcinoma (HCC), based on established criteria. Pre‐transplant imaging occasionally underestimates the tumor burden or biological aggressiveness, leading to explant pathology that exceeds the projection criteria, such as Milan.
Serkan Sucu +2 more
wiley +1 more source
Perspectives in Surgery of Oligometastatic Non-Small-Cell Lung Cancer [PDF]
, 2015 20-50% of patients with newly diagnosed non-small-cell lung cancer (NSCLC) have synchronous metastases. This dramatically affects survival and traditionally excludes patients from the spectrum of curative therapies.
Stefano Cafarotti +2 more
core
Modern approach in oligometastatic prostate cancer therapy [PDF]
Medicinski Podmladak, 2023 Oligometastatic disease is defined as an intermediate state between localized and widespread metastatic disease. Oligometastatic prostate cancer is generally defined by the presence of five or fewer metastatic sites on imaging.
Stanić Jelena +3 more
doaj
Stereotactic Prostate Cancer Ablative Re‐Irradiation: A Systematic Review and Meta‐Analysis (SPARE)
The Prostate, EarlyView.ABSTRACT Background Stereotactic ablative radiotherapy (SABR) is emerging as an alternative treatment for patients with locally recurrent prostate cancer after previous radiation. This approach allows for precise target coverage while limiting toxicity to surrounding organs.
Andre G. Gouveia +12 more
wiley +1 more source
Chemotherapy for oligometastatic prostate cancer
, 2017 PURPOSE OF REVIEW: To analyze recent trials of upfront chemotherapy to determine how this paradigm can be applied to oligometastatic prostate cancer patients.
Dorff, Tanya B. +3 more
core +1 more source
Abscopal effect as part of treatment of oligometastatic head and neck cancer: A case report
Clinical Case Reports, 2021 A 66‐year‐old man with hypopharyngeal carcinoma with a single bone metastasis was treated with definitive chemo/radiotherapy omitting local treatment of the single bone lesion. He remained relapse‐free for 6 years.
Giulia Mazzaschi +6 more
doaj +1 more source
BJU International, EarlyView.Background Prostate cancer (PCa) is the second most common cancer in men. For patients with high‐volume metastatic PCa (mPCa) who are fit for docetaxel, a triplet therapy regimen consisting of androgen deprivation therapy (ADT), chemotherapy, and an androgen receptor pathway inhibitor (ARPI) is recommended.
Xiangwei Yang +7 more
wiley +1 more source
Risk factors and management of oligometastatic non-small cell lung cancer
Therapeutic Advances in Respiratory Disease, 2016 Non-small cell lung cancer (NSCLC) is an aggressive malignancy with close to half of all patients presenting with metastatic disease. A proportion of these patients with limited metastatic disease, termed oligometastatic disease, have been shown to ...
Akshar N. Patel +2 more
doaj +1 more source